Synopsis
This book is tailored to the medical device industry professional and discusses the evolution of strategies and structures required for successful product market access. Rising health care costs have led to changes in how budget expenditures are assessed and allocated, introducing a Value Era of cost containment where payers now act as gatekeepers to the marketplace and physician s awareness of a new product is no longer sufficient to ensure its adoption. By considering value metrics payers increasingly use, companies can create research, development and commercialization processes that optimize their products potential for successful market access. The solutions described in this book are provided in the context of medical device industry but are also relevant and applicable to pharmaceutical products and will promote the comprehensive identification, development, and communication of product value in an environment where such value is essential to commercial success.
Review
This comprehensive yet concisely-written book offers solutions for industry executives navigating through the complicated terrain of today s market access hurdles. These solutions have originated through an innovative, strategic approach and are well-supported by contemporary evidence --Dr. Campbell Rogers, Chief Medical Officer, HeartFlow, Inc.
Succeeding in the Changed Medical Device Market methodically embraces the shift to a value-driven market with the goal of optimizing health in a time of constrained resources. The authors have combined their complementary and considerable experience in health outcomes, reimbursement, health policy and pricing, as well as Ryan s experience in all sectors of the global health care system to develop this forward-thinking and didactic book for those needing to understand the market access landscape for medical technologies --Dr. Georges Gemayel, Chairman of Syndexa Pharmaceuticals and Vascular Magnetics Inc.
Dr. Ryan Saadi and co-authors have intelligently captured the new and evolving requirements for market access of medical technologies. Their book provides an evidence-based thought process that serves to provoke innovative change in a time of exceptional need --Dr. Bruce Cooper, Head, Global Medical Affairs, Hoffmann-La Roche Ltd
"About this title" may belong to another edition of this title.